New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
09:49 EDTBCRXBioCryst, HHS extend peramivir agreement for 31 days
BioCryst Pharmaceuticals disclosed that it and the U.S. Department of Health and Human Services mutually agreed to extend their agreementís current expiration date of February 28 for 31 days. The new expiration date is changed to March 31. The extension of the agreement will allow ongoing stability testing of peramivir to continue beyond the current contract expiration date. All other terms and conditions of the agreement remain unchanged.
News For BCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 18, 2015
15:17 EDTBCRXBioCryst management to meet with JPMorgan
Subscribe for More Information
May 13, 2015
07:00 EDTBCRXBioCryst initiates Phase 1 clinical trial of angioedema candidate
Subscribe for More Information
May 8, 2015
09:47 EDTBCRXBioCryst sees FY15 net operating cash use $65M-$80M
Subscribe for More Information
09:47 EDTBCRXBioCryst says OPuS-2 clinical trial proceeding as planned
Subscribe for More Information
09:16 EDTBCRXBioCryst sees FY15 net operating cash use $65M-$80M
Subscribe for More Information
09:15 EDTBCRXBioCryst says OPuS-2 clinical trial proceeding as planned
Subscribe for More Information
09:15 EDTBCRXBioCryst reports Q1 EPS (21c), consensus (25c)
Reports Q1 revenue $6.83M, consensus $4.3M

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use